Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
I confirm I am 21 years or older I am purchasing strictly for laboratory research purposes only I understand these products are not for human or veterinary use By clicking "I Agree", you confirm your understanding and acceptance of our terms.
9M B12 PFS Injection is generally safe and does not usually cause any common side effects
Most of these uses come from cell and animal studies, not large human trials
What did you feel